Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data
Crossref DOI link: https://doi.org/10.1186/s10194-017-0802-6
Published Online: 2017-09-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Davies, Brendan
Gaul, Charly
Martelletti, Paolo
García-Moncó, Juan Carlos
Brown, Stephanie
Funding for this research was provided by:
Allergan plc
License valid from 2017-09-06